← Back to Professional, Scientific, and Technical Services

Research and Development in Biotechnology

Industry Overview

Stock Screener

Select filters to narrow down the 175 companies below

175 companies
$0B >$1T

Ratio between share price and earnings per share. A low ratio could indicate undervaluation.

<0 >50

Ratio of dividends in the last 12 months to current share price.

0% 3%

Revenue increase compared to the same quarter one year ago.

0% 30%

Net income increase compared to the same quarter one year ago.

0% 30%

Profitability of the last quarter.

<-30% >30%

A higher ratio indicates a higher risk. The ratio is difficult to compare between industries.

<0 >3

Discounted cash flow valuation vs. current price. Positive = undervalued, negative = overvalued.

<-50% >+100%
Market Cap
Dividends Ratio of dividends in the last 12 months to current share price
P/E Ratio
Revenue Revenue of the last quarter YoY Change
Net income Net income of the last quarter YoY Change
Profit margin Profit margin of the last quarter

CSL Ltd. - ADR

CSLLY

CSL Ltd. - ADR

CSLLY
Market Cap $73.57B
Dividends 3.7%
P/E Ratio 27.4
Revenue $8.3B +1.1%
Net Income $402M -80.0%
Profit Margin +4.8%
View Stock

Exact Sciences Corp.

EXAS

Exact Sciences Corp.

EXAS
Market Cap $20.03B
Dividends 0.0%
P/E Ratio -95.7
Revenue $878M +23.1%
Net Income -$86M -90.1%
Profit Margin -9.8%
View Stock

Genmab - ADR

GMAB

Genmab - ADR

GMAB
Market Cap $15.51B
Dividends 0.0%
P/E Ratio 18.9
Revenue $899M +25.8%
Net Income $53.2M -72.7%
Profit Margin +5.9%
View Stock

Medpace Holdings Inc

MEDP

Medpace Holdings Inc

MEDP
Market Cap $13.14B
Dividends 0.0%
P/E Ratio 28.4
Revenue $707M +26.5%
Net Income $124M +8.1%
Profit Margin +17.5%
View Stock

Exelixis Inc

EXEL

Exelixis Inc

EXEL
Market Cap $13.05B
Dividends 0.0%
P/E Ratio 16.6
Revenue $611M +10.0%
Net Income $210M +31.9%
Profit Margin +34.5%
View Stock

Icon Plc

ICLR

Icon Plc

ICLR
Market Cap $11.18B
Dividends 0.0%
P/E Ratio 23.4
Revenue $2.19B +7.3%
Net Income -$110M -142.4%
Profit Margin -5.0%
View Stock

Nuvalent Inc - Ordinary Shares - Class A

NUVL

Nuvalent Inc - Ordinary Shares - Class A

NUVL
Market Cap $9.08B
Dividends 0.0%
P/E Ratio -21.6
Revenue $0.00
Net Income -$109M +29.2%
Profit Margin
Employees 2.02K
View Stock

Charles River Laboratories International Inc.

CRL

Charles River Laboratories International Inc.

CRL
Market Cap $8.91B
Dividends 0.0%
P/E Ratio -49.3
Revenue $996M +1.2%
Net Income -$14.8M -158.3%
Profit Margin -1.5%
Employees 17K
View Stock

Immunovant Inc

IMVT

Immunovant Inc

IMVT
Market Cap $7.26B
Dividends 0.0%
P/E Ratio -14.2
Revenue $0.00 -100.0%
Net Income -$148M +38.9%
Profit Margin
View Stock

Abivax - ADR

ABVX

Abivax - ADR

ABVX
Market Cap $6.5B
Dividends 0.0%
P/E Ratio -17.6
Revenue -$2.02M -200.7%
Net Income -$222M +369.4%
Profit Margin +11009.1%
View Stock

Scholar Rock Holding Corp

SRRK

Scholar Rock Holding Corp

SRRK
Market Cap $5.67B
Dividends 0.0%
P/E Ratio -14.7
Revenue $0.00
Net Income -$106M +41.2%
Profit Margin
View Stock

Abcam - ADR (Sponsored)

ABCM

Abcam - ADR (Sponsored)

ABCM
Market Cap $5.52B
Dividends 0.0%
P/E Ratio 578.4
Revenue $102M +9.7%
Net Income $8.4M +189.7%
Profit Margin +8.3%
Employees 2.02K
View Stock

Twist Bioscience Corp

TWST

Twist Bioscience Corp

TWST
Market Cap $5.45B
Dividends 0.0%
P/E Ratio -66.5
Revenue $111M +19.3%
Net Income -$44M +11.9%
Profit Margin -39.8%
View Stock

Mirum Pharmaceuticals Inc

MIRM

Mirum Pharmaceuticals Inc

MIRM
Market Cap $5.38B
Dividends 0.0%
P/E Ratio -7.9
Revenue $0.00 -100.0%
Net Income -$790M +5283.6%
Profit Margin
View Stock

Syneos Health Inc - Class A

SYNH

Syneos Health Inc - Class A

SYNH
Market Cap $4.46B
Dividends 0.0%
P/E Ratio 16.6
Revenue $1.37B +0.4%
Net Income $793k -99.0%
Profit Margin +0.1%
Employees 23K
View Stock

Erasca Inc

ERAS

Erasca Inc

ERAS
Market Cap $4.25B
Dividends 0.0%
P/E Ratio -14.7
Revenue $0.00
Net Income -$183M +492.4%
Profit Margin
Employees 2.02K
View Stock

Crinetics Pharmaceuticals Inc

CRNX

Crinetics Pharmaceuticals Inc

CRNX
Market Cap $3.78B
Dividends 0.0%
P/E Ratio -7.0
Revenue $10.7M +2873.4%
Net Income -$128M +32.1%
Profit Margin -1191.0%
View Stock

Tango Therapeutics Inc

TNGX

Tango Therapeutics Inc

TNGX
Market Cap $3.48B
Dividends 0.0%
P/E Ratio -37.4
Revenue $0.00 -100.0%
Net Income -$45.5M +14.1%
Profit Margin
Employees 4
View Stock

Dianthus Therapeutics Inc

DNTH

Dianthus Therapeutics Inc

DNTH
Market Cap $3.44B
Dividends 0.0%
P/E Ratio -749.9
Revenue $0.00 -100.0%
Net Income -$40.8M +38.4%
Profit Margin
Employees 81
View Stock

Ideaya Biosciences Inc

IDYA

Ideaya Biosciences Inc

IDYA
Market Cap $2.95B
Dividends 0.0%
P/E Ratio -19.8
Revenue $6.56M
Net Income -$98.5M +38.0%
Profit Margin -1502.1%
View Stock